MagicMed Industries Announces Collaboration with Artificial Intelligence Thought Leaders and the Launch of PsyAI™
CALGARY, AB, March 4, 2021 – MagicMed Industries Inc. (CSE: MGIC reserved) (“MagicMed” or the “Company“) announced today a collaboration among the Company, Dr. Suran Goonatilake and Dr. Eric Nyberg, renowned thought leaders in artificial intelligence (“AI”). Together the parties are building PsyAI™, a tool designed to provide comprehensive, pharmaceutical design, manufacturing, pharmacology predictive and validating methodologies in an effort to modernize psychedelic medicine.
The standard pharmaceutical candidate screening process is a consistent bottleneck in bringing standard pharmaceutical candidates to market and acts as a primary determinant of eventual clinical success or failure. This paradigm is particularly challenging in the psychedelics pharmaceutical sector, owing to a limited understanding of the mechanisms underlying observed clinical data. Similarly, the correlation between the actual physical structure of psychedelic agents and patient outcomes is unknown. The strict regulatory regimes in place for the last five decades have only recently been relaxed and have inhibited critical basic research in this sector and put the already challenging drug development process at an even greater disadvantage.
Combining PsyAI™ and the Psybrary™, MagicMed’s large-scale novel molecule creation platform, creates an opportunity to accelerate the development of optimized pharmaceutical candidates, each tailored specifically for difficult-to-treat mental health indications.
MagicMed’s Chief Scientific Officer, Dr. Peter Facchini, stated “It is an exceptional opportunity, and indeed and honour, to be allayed with two internationally respected thought leaders in AI, upholding the Company’s core tenet of engaging with industry leaders. Dr. Suran Goonatilake and Dr. Eric Nyberg, whose ground-breaking developments have helped shaped aspects of AI for decades, have agreed to join us in solving a fundamental challenge: the quest to develop new therapies for devastating mental health conditions”.
Dr. Suran Goonatilake, Visiting Professor, UCL Centre for Artificial Intelligence, and co-founder of April 19 Discovery Inc., has a track record in developing new AI methods and applying them to address some of the world’s hardest problems. Through his PhD research in intelligent hybrid systems, he co-founded SearchSpace (acquired by Warburg Pincus), one of the world’s first AI platforms to detect complex patterns in financial transactions ranging from insider-dealing detection at stock exchanges to money laundering detection at retail banks. Dr. Goonatilake commented, “2021 is an exciting point in history. Three major disciplines are converging: AI-driven drug-discovery, synthetic biology and the ‘psychedelic renaissance’ to treat mental health conditions. It’s very exciting to be at the nexus of this convergence.”
He added, “I am honoured to collaborate with Dr. Nyberg to take MagicMed’s library of psychedelic compounds – PsybraryTM – and apply deep-learning methods to move them along the pipeline towards APIs (active pharmaceutical ingredients). We believe that every AI module increases the value of a compound as a potential therapeutic by leveraging AI systems to replace human scientists and thereby reducing the time and cost to bring a therapeutic to market.”
Dr. Eric Nyberg, Chief Data Scientist at Cognistx (Cognistx.com)and Professor at Carnegie Mellon University, was a member of the original IBM Watson development team and also developed scalable architecture for multi-strategy question-answering systems. Dr. Nyberg stated, “It is my view that the need in society has never been greater for great minds to come together and pool resources to solve a serious and growing problem in society. I am pleased to have the opportunity to collaborate with Dr. Goonatilake and MagicMed, to build upon a classification and clustering matrix and ultimately deploy a tier-based model that designs structures, optimizes synthesis processes, and predicts biophysical properties from receptor binding and pharm/tox through to patient outcomes in distinct clinical indications. I believe that the need for, and thus value of, the development of this new tool we are building to revolutionize the psychedelic medicine sector cannot be overstated”.
Drs. Goonatilake’s and Nyberg’s contributions will be delivered through their AI companies, April 19 Discovery Inc. and Cognistx, respectively.
PsyAITM, PsybraryTM, MagicMedTM, and MagicMed IndustriesTM are trademarks of MagicMed Industries Inc., submitted for registration in the USA and Canada.
About MagicMed
MagicMed Industries intends to partner with pharmaceutical and other companies to develop and commercialize psychedelic-derived pharmaceutical candidates. MagicMed’s psychedelic derivatives library, the Psybrary™, is anticipated to be an essential building block from which industry can develop new patented products. The initial focus of the Psybrary™ is on psilocybin and DMT derivatives, and it is then expected to be expanded to other psychedelics such as MDMA, LSD, mescaline, and ibogaine.
About Cognistx
Founded in 2015, Cognistx is a Pittsburgh-based applied AI company, building multi-strategy AI systems for clients across the U.S. Cognistx create AI-powered computer systems that can sense, learn, and act. The company founders are pioneers in the fields of automatic question-answering, speech processing, computer vision, natural language processing (NLP), and applied machine learning. The team at Cognistx is able to efficiently combine and customize the best advanced technologies- their AI building blocks – to create applications that extract meaningful insights to produce measurable impacts for their clients. VisitCognistx.com
About April 19 Discovery Inc.
April 19 is an AI-driven drug-discovery company entirely focused on developing and screening novel compounds for psychedelic medicine. The ‘psychedelic renaissance’ promises to provide much needed therapies to treat depression, PTSD, anxiety, addiction cessation and other mental health conditions. Salina is a division of April 19 that is developing AI-driven biomarkers (e.g. EEG analytics) to automatically detect adverse events (e.g. cardiac arrests) to increase safety in this emerging industry. A long-term goal is to fundamentally change the economics of this new sector by reducing clinical reliance on medical personnel and lower the cost-per-patient within FDA-approved treatment protocols. Visitwww.april19.ai
For further information, please contact MagicMed Industries Inc. Investor Relations at [email protected]or visit our website at www.magicmedindustries.com.
Forward Looking Statements
This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions and accordingly, actual results and future events could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. All statements other than statements of present or historical fact are forward-looking statements, including statements with respect to MagicMed’s future business plans and partnerships, management’s perception of both Dr. Suran Goonatilake and Dr. Eric Nyberg, their standing in the AI space and the impact their partnership may have on the Company, management’s views regarding the particular challenges in the psychedelics pharmaceutical sector, the anticipated effect that combining PsyAI™ and the Psybrary™ will have and the proposed benefits to the psychedelics pharmaceutical sector and the anticipated uses of MagicMed’s patents and the development of the Psybrary™. Forward-looking statements include words or expressions such as “proposed”, “anticipated”, “will”, “subject to”, “near future”, “in the event”, “would”, “expect”, “prepared to” and other similar words or expressions.
Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements. Some of the risks and other factors could cause results to differ materially from those expressed in the forward-looking statements which include, but are not limited to: the ability of MagicMed to secure patent protection; the regulatory environment in which MagicMed operates; the ability of MagicMed to enter into partnership agreements or other arrangements; the ability of MagicMed to carry out its business plans (including but not limited to its plans to file a non-offering prospectus and apply to list on a stock exchange) and unforeseen challenges in carrying out such plans; the development and expansion of the Psybrary™; trends in the future use of psilocybin; general business, economic, competitive, political and social uncertainties; the state of capital markets; risks relating to general economic, market and business conditions; and other unforeseen events, developments, or factors causing any of the aforesaid expectations, assumptions, and other factors ultimately being inaccurate or irrelevant. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We disclaim any obligation to update or revise these forward-looking statements, except as required by applicable law.
Existing customers on eligible Business Internet and SmartWiFi 150 and 300 plans will also have their download speeds doubled to 300 Mbps and 600 Mbps respectively, at no additional charge Significant investments into Shaw’s fibre ... [Read]
PR Newswire HOUSTON, Feb. 21, 2019 HOUSTON, Feb. 21, 2019 /PRNewswire/ — Following a period of industry consultation, S&P Global Platts, the leading independent provider of information and benchmark prices for the commodities and energy markets, today ... [Read]
Vancouver, British Columbia–(Newsfile Corp. – February 6, 2019) – Genesis Metals Corp (TSXV:GIS) (“Genesis” or the “Company”) is pleased to announce a new resource estimate for the 100% owned Chevrier gold project located near Chibougamau, ... [Read]
TORONTO, Dec. 19, 2018 /CNW/ – Sunwah International Limited, TSXV:SWH (the “Company”), a Hong Kong based investment firm and a member of major Asian conglomerate, Sunwah Group, announces that the Toronto Stock Exchange (the “TSX”) has extended by 30 ... [Read]
TORONTO, Dec. 14, 2018 (GLOBE NEWSWIRE) — Unisync Corp. (TSXV:UNI) (“Unisync“) is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to list its common shares on the TSX. ... [Read]
This Post Was Syndicated Under License Via QuoteMedia 22/11/2018 Barcelona-based vendor recognized for industry leadership and promoting new collaborative models in Enterprise Security and Enterprise Threat Detection London, UK – Blueliv, a leading enterprise-class ... [Read]
Syndicated via bluebirdbatterymetals Vancouver, British Columbia, August 15, 2018 – BlueBird Battery Metals Inc. (TSXV:BATT; US: BBBMF) (the “Company” or “BlueBird”) is pleased to announce that it has received all permits necessary for its initial drill ... [Read]
A native Canadian firm, Optimi Health Corp. (OPTI:CNX), makes synthetic formulations for transformative human experiences as well as natural, scaleable, and affordable psychedelic and functional mushrooms. The organization is included on Health Canada’s list of ... [Read]
Cardinal Health (NYSE:CAH) recently announced steps to position the Company for long-term success, expanding on previously disclosed expansion goals. Elliott Investment Management L.P. (“Elliott”) provided feedback on these efforts. Elliott has also signed a collaboration ... [Read]
Disclaimer
Statements & Policies
Summary of Disclosures
By accessing MicroSmallCap.com (hereinafter referred to as “this website”) you hereby affirmatively represent to Market Jar Media Inc. (“Market Jar”) that you have read and understood the entirety of the following statements and policies
If you do not agree to these Statements & Policies, you may not use the MicroSmallCap.com website and affirmatively acknowledge that you have not used or viewed content on the MicrosSmallCap.com website
Market Jar is neither an investment advisor nor broker-dealer. The information presented on the MicrosSmallCap.com website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on MicrosSmallCap.com constitutes advice easeor a recommendation.
The opinions and analyses included in this website are based on factual information obtained from public filings and other sources deemed to be reliable and are provided “as is” in good faith. Market Jar makes no representation or warranty, expressed, implied or statutory, as to the accuracy or completeness of such information, which may be subject to change without notice.
Safe Harbor Statement
This website contains forward-looking statements applicable to future anticipated performance, growth, and plans of the companies on whose behalf we disseminate information. As such, any specific statement on this website that are not statements of factual history should be viewed as forward-looking statements. These forward-looking statements can be generally identified through phrases such as “possibly”, “anticipates”, “estimates”, “potentially”, “intends”, and other words of similar connotation. Statements in this website that speak to a company’s business intentions, objectives, strategies, and or intentions should also be viewed as forward-looking statements. All forward-looking statements are subject to uncertainties that could result in different outcomes than those described in forward-looking statements.
Terms of Use
By accessing this website, you indicate your agreement to these Statements & Policies. You affirmatively represent that you have read and understood the entirety of the following Statements & Policies. We reserve the right, at our discretion, to change, modify, and add or delete portions of such Statements & Policies at any time.
Copyright
The entire contents of this site are protected by worldwide copyright laws and treaty provisions. The contents of this website are for non-commercial individual reference only and may not be used for other purposes or otherwise copied, displayed, downloaded, distributed, modified, reproduced, republished or retransmitted without the express written consent of Market Jar.
Information subject to change
Information on this website is updated regularly by Market Jar without notice. However, the information is not intended to be complete and cover all matters and developments concerning the company and its activities and the company cannot guarantee either the currency or completeness of the information at all times and assumes no responsibility in this regard.
Price quotes
All stock quotes are delayed at least 15 minutes unless otherwise noted. All stock quotes or cryptocurrency price quotes (collectively “Quotes”) and historical price data are provided by a third party service provider and are provided for information purposes only and not for trading purposes. Market Jar makes no representation or warranty regarding the accuracy or completeness of any Quotes or historical price data and has not verified the adequacy, accuracy or completeness of the information provided on this website. We strongly recommend that you seek independent professional advice before investing in any companies, stock or cryptocurrency mentioned in the articles on the website.
Notice to investors
The information on this website is not intended as a solicitation for funds or an offering of securities and should not be construed or interpreted as such. The information on this website is not intended to modify, qualify, supplement or amend information disclosed under applicable securities legislation of the U.S. or Canada. No securities commission or other regulatory authority in either the U.S. or Canada has in any way passed upon the information on this website and Market Jar makes no representation or warranty to that effect.
Social Media Terms of Use/ Disclaimer
Market Jar supports the use of social media, however any third party content posted through social media channels maintained by us should not be taken as an endorsement of such information. Links to websites and other resources operated by third parties (“Third Party Information”) other than Market Jar are provided solely as a convenience to the user. We do not control such Third Party Information and are not responsible and disclaim any liability for the content, products, services or information offered by any third parties. The inclusion of links to such Third Party Information on the page does not imply endorsement of any content, products or services offered, advertised, endorsed or promoted by any third party, or of any company or person. If you decide to access any Third Party Information or acquire any third party products or services, you do so entirely at your own risk, and you may be subject to the terms and conditions and the privacy policies imposed by such third parties. Third party sources generally state that the information contained therein has been obtained from sources believed to be reliable, but there can be no assurance as to the accuracy or completeness of included information. Although believed to be reliable, management of Market Jar has not independently verified any of the data from third party sources.
Ownership and Interests
MicrosSmallCap.com is owned by Market Jar. Market Jar, and its directors and officers do not own any of the shares in the companies mentioned in this article.
Amounts Paid To Market Jar Media Inc.
Market Jar Media Inc. has or expects to receive the following amounts indirectly from the issuer’s set forth below.
Sponsored Posts = $197 USD
Press Release = $197 USD
Amounts noted above were received or expected to be received directly from Market Jar Media Inc., which was directly engaged by the issuers set forth above.
Disclaimer
Neither Market Jar nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment advisor or broker-dealer or associated person with a registered investment advisor or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company or any cryptocurrency on the MicrosSmallCap.com website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. Therefore, information on this website is not intended to be, and shall not substitute, an offer to sell nor the solicitation of any offer to buy any security.
The opinions and analysis included in this website related to the profiled companies represent the personal and subjective views of the author of the articles, and are subject to change at any time without notice. The information provided in the articles on the website and the content has been obtained from sources which the authors believe to be reliable. However, the authors have not independently verified or otherwise investigated all such information. None of the authors, Market Jar, Market Jar Media Inc., or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The opinion, analysis, articles and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission, the Canadian security regulatory authorities, or any other regulatory authority before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
Information obtained from public filings and other sources are deemed reliable; however, Market Jar take no responsibility for verifying the accuracy of such information and makes no representation that such information is complete and correct. Market Jar makes no representation or guarantee that any forward-looking statements will prove to be accurate. Persons using the MicrosSmallCap.com website are encouraged to consult with independent financial advisors with respect to an investment in any company profiled in the website. Investors should therefore verify independently information provided in the MicrosSmallCap.com website by completing their due diligence on any company in which their clients are contemplating an investment. Such information to be reviewed could include the company’s annual reports, regulatory filings, and press releases on the sec.gov or www.sedar.com website or directly from the issuer.
Risk Warnings
The content published on this website is intended for and only to be used for reference purposes and is neither an offer nor a solicitation to purchase or sell any security or instrument or to participate in any particular trading strategy. No such information provided through the MicrosSmallCap.com website constitutes advice or a recommendation that any investment or trading strategy is suitable for any specific person. Users of this website agree that they are not using any content of this website in connection with an investment decision.
THERE CAN BE NO ASSURANCE THAT CONTENTS PUBLISHED ON MICROSMALLCAP.COM IS ACCURATE OR WITHOUT ERROR. ANY PERSON WHO MAKES USE OF SUCH CONTENT AFFIRMATIVELY ASSUMES ALL RISKS FROM USING THE CONTENT. MicrosSmallCap.com does not guarantee it reviews, and is not responsible for confirming the accuracy of information submitted for inclusion on this site. INVESTORS ARE STRONGLY ADVISED TO CONFIRM THE ACCURACY OF ANY INFORMATION OBTAINED FROM THIS SITE PRIOR TO MAKING ANY INVESTMENT DECISION.
OTC Risk Warnings
Because many securities traded Over-The-Counter (OTC) are relatively illiquid, or “thinly traded,” which tends to increase volatility in market prices, an investment in an OTC security involves a high degree of risk. These speculative and illiquid securities are often difficult for investors to buy or sell without significantly affecting the quoted price. It should be noted that the liquidation of a position in an OTC security may not even be possible within a reasonable period of time.
Dependable information regarding issuers of OTC securities, their prospects, or the risks associated with the business of any particular issuer or an investment in the issuer’s securities may not be available. For this reason, it may be difficult to properly value an investment in an OTC security or accurately determine the risks involved with investing in such a security. For more information about investing in microcap securities, please read the content on the SEC’s website, including the SEC’s investor publication titled “Microcap Stock: A Guide for Investors” available at https://www.sec.gov/investor/pubs/microcapstock.htm.
Issuers of OTC securities quoted on the OTC Link system are not required to provide any kind of information to investors. While many issuers register OTC securities with the Securities and Exchange Commission (SEC) and regularly provide reports to investors in connection with such registration, they are not required to continue such registration or regularly provide such reports because their securities are quoted on OTC Link. Securities may continue to be quoted on the OTC Link system if issuers are delinquent in their reporting obligation to the SEC or other federal or state regulatory agencies. Quotation of a security on the OTC Link system does not in itself create any ongoing filing or reporting obligations with the SEC for any issuer. In fact, issuers may not even be aware that their securities are quoted on the OTC Link system.
The information on this website has been prepared for information purposes only and does not constitute an offer to sell or trade, a solicitation to buy, or recommendation for any security, cryptocurrency, ICO or related product, nor does it constitute an offer to provide investment advice or other related services by Market Jar Media Inc., or any of its principals, agents, owners, members or anyone else affiliated with the company, either expressly or indirectly. In preparing the information contained on this website, no individual financial or investment needs of the recipient have been taken into account nor is any financial or investment advice being offered. Any views expressed in on this website were prepared based upon the information available at the time such views were written. Changed or additional information could cause such views to change and Market Jar is under no obligation to provide notice of such information or update such views.
